Carboplatin binding to histidine
Carboplatin binding to histidine
Loading...
Date
2014
Authors
Tanley, Simon W. M.
Kroon-Batenburg, Loes M. L.
Levy, Colin
Schreurs, Aontoine M. M.
Helliwell, John R.
Editors
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
URI (citable link)
DOI (citable link)
International patent number
Link to the license
EU project number
Project
Open Access publication
Collections
Title in another language
Publication type
Journal article
Publication status
Published in
Acta Crystallographica Section F : Structural Biology and Crystallization Communications ; 70 (2014), 9. - pp. 1135-1142. - eISSN 1744-3091
Abstract
Carboplatin is a second-generation platinum anticancer agent used for the treatment of a variety of cancers. Previous X-ray crystallographic studies of carboplatin binding to histidine (in hen egg-white lysozyme; HEWL) showed the partial conversion of carboplatin to cisplatin owing to the high NaCl concentration used in the crystallization conditions. HEWL co-crystallizations with carboplatin in NaBr conditions have now been carried out to confirm whether carboplatin converts to the bromine form and whether this takes place in a similar way to the partial conversion of carboplatin to cisplatin observed previously in NaCl conditions. Here, it is reported that a partial chemical transformation takes place but to a transplatin form. Thus, to attempt to resolve purely carboplatin binding at histidine, this study utilized co-crystallization of HEWL with carboplatin without NaCl to eliminate the partial chemical conversion of carboplatin. Tetragonal HEWL crystals co-crystallized with carboplatin were successfully obtained in four different conditions, each at a different pH value. The structural results obtained show carboplatin bound to either one or both of the N atoms of His15 of HEWL, and this particular variation was dependent on the concentration of anions in the crystallization mixture and the elapsed time, as well as the pH used. The structural details of the bound carboplatin molecule also differed between them. Overall, the most detailed crystal structure showed the majority of the carboplatin atoms bound to the platinum centre; however, the four-carbon ring structure of the cyclobutanedicarboxylate moiety (CBDC) remained elusive. The potential impact of the results for the administration of carboplatin as an anticancer agent are described.
Summary in another language
Subject (DDC)
570 Biosciences, Biology
Keywords
carboplatin, histidine, avoid partial conversion to cisplatin, NaBr crystallization conditions, non-NaCl crystallization conditions, model protein (hen egg-white lysozyme)
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690
TANLEY, Simon W. M., Kay DIEDERICHS, Loes M. L. KROON-BATENBURG, Colin LEVY, Aontoine M. M. SCHREURS, John R. HELLIWELL, 2014. Carboplatin binding to histidine. In: Acta Crystallographica Section F : Structural Biology and Crystallization Communications. 70(9), pp. 1135-1142. eISSN 1744-3091. Available under: doi: 10.1107/S2053230X14016161BibTex
@article{Tanley2014Carbo-29341, year={2014}, doi={10.1107/S2053230X14016161}, title={Carboplatin binding to histidine}, number={9}, volume={70}, journal={Acta Crystallographica Section F : Structural Biology and Crystallization Communications}, pages={1135--1142}, author={Tanley, Simon W. M. and Diederichs, Kay and Kroon-Batenburg, Loes M. L. and Levy, Colin and Schreurs, Aontoine M. M. and Helliwell, John R.} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29341"> <dc:creator>Helliwell, John R.</dc:creator> <dc:contributor>Helliwell, John R.</dc:contributor> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:rights>terms-of-use</dc:rights> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Schreurs, Aontoine M. M.</dc:creator> <dc:language>eng</dc:language> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/29341/1/Tanley_0-258990.pdf"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Diederichs, Kay</dc:creator> <dcterms:abstract xml:lang="eng">Carboplatin is a second-generation platinum anticancer agent used for the treatment of a variety of cancers. Previous X-ray crystallographic studies of carboplatin binding to histidine (in hen egg-white lysozyme; HEWL) showed the partial conversion of carboplatin to cisplatin owing to the high NaCl concentration used in the crystallization conditions. HEWL co-crystallizations with carboplatin in NaBr conditions have now been carried out to confirm whether carboplatin converts to the bromine form and whether this takes place in a similar way to the partial conversion of carboplatin to cisplatin observed previously in NaCl conditions. Here, it is reported that a partial chemical transformation takes place but to a transplatin form. Thus, to attempt to resolve purely carboplatin binding at histidine, this study utilized co-crystallization of HEWL with carboplatin without NaCl to eliminate the partial chemical conversion of carboplatin. Tetragonal HEWL crystals co-crystallized with carboplatin were successfully obtained in four different conditions, each at a different pH value. The structural results obtained show carboplatin bound to either one or both of the N atoms of His15 of HEWL, and this particular variation was dependent on the concentration of anions in the crystallization mixture and the elapsed time, as well as the pH used. The structural details of the bound carboplatin molecule also differed between them. Overall, the most detailed crystal structure showed the majority of the carboplatin atoms bound to the platinum centre; however, the four-carbon ring structure of the cyclobutanedicarboxylate moiety (CBDC) remained elusive. The potential impact of the results for the administration of carboplatin as an anticancer agent are described.</dcterms:abstract> <dc:creator>Levy, Colin</dc:creator> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:creator>Tanley, Simon W. M.</dc:creator> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/29341/1/Tanley_0-258990.pdf"/> <dc:contributor>Tanley, Simon W. M.</dc:contributor> <dc:contributor>Kroon-Batenburg, Loes M. L.</dc:contributor> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/29341"/> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-11-27T11:52:45Z</dcterms:available> <dcterms:title>Carboplatin binding to histidine</dcterms:title> <dc:creator>Kroon-Batenburg, Loes M. L.</dc:creator> <dc:contributor>Schreurs, Aontoine M. M.</dc:contributor> <dc:contributor>Levy, Colin</dc:contributor> <dcterms:issued>2014</dcterms:issued> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:contributor>Diederichs, Kay</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-11-27T11:52:45Z</dc:date> </rdf:Description> </rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Examination date of dissertation
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
Yes